We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA WARNS SATELEC ON MDR, QUALITY VIOLATIONS
FDA WARNS SATELEC ON MDR, QUALITY VIOLATIONS
February 20, 2004
A French firm's failure to translate its 483 response letter and supporting documents into English prior to submitting them to the FDA may have lead to an avoidable warning letter.